NSAIDs and covid-19: What have we learned?
Article written by Christine Clark In the early days of the coronavirus pandemic there was concern that the use of non-steroidal anti-inflammatory drugs might be harmful and people… read more.
The latest coronavirus developments and scientific research on prevention and treatment.
Article written by Christine Clark In the early days of the coronavirus pandemic there was concern that the use of non-steroidal anti-inflammatory drugs might be harmful and people… read more.
Article written by Christine Clark The similarities between the ACE-inhibitor cough and the cough of covid-19 prompted Dr Colin Brown, a retired GP and researcher, to investigate further…. read more.
Article written by Christine Clark The similarities between the ACE-inhibitor cough and the cough of covid-19 prompted Dr Colin Brown, a retired GP and researcher, to investigate further…. read more.
Article written by Christine Clark Retired GP and researcher Dr Colin Brown realised that the similarities between the ACEI cough and covid-19 cough suggested a common cause and… read more.
Article written by Peter Mas-Mollinedo With the outbreak of the Pandemic and the lingering worries of COVID-19 pharmaceutical sales and marketing has taken a hit. There are no… read more.
One in four older Americans had a virtual medical visit in the first three months of the COVID-19 pandemic, most of them by video, a new telehealth poll finds.
Article written by Gary Finnegan China’s control measures during the first 50 days of the COVID-19 epidemic may have delayed the spread of the virus to cities outside… read more.
Article written by Bruce Sylvester. Current smokers and those with chronic obstructive pulmonary disease COPD suffer greater COVID-19 severity and greater COVID-19 related mortality..
Pfizer Inc. and BioNTech SE announced the start of a global (except for China) Phase II/III safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA… read more.
Health Canada has approved, with conditions, remdesivir (Velkury) from Gilead Sciences to treat COVID-19 patients. Remdesivir is used to treat those with pneumonia who need extra oxygen to… read more.
Moderna announced a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) for an additional commitment of up to $472 million to support late… read more.
Glenmark announced Phase III results that showed its antiviral treatment favipiravir demonstrated a 28.6% faster viral clearance of COVID-19 compared to placebo . Favipiravir is a broad-spectrum oral… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.